Chemical Name: Tamoxifen Citrate, Nolvadex
CAS NO.: 54965-24-1
Molecular Formula: C26H29NO.C6H8O7
Molecular weight: 563.64
MP: 140-144 ºC
Appearance: white crystalline powder.
Tamoxifen Citrate Description:
Nolvadex (tamoxifen citrate) is very comparable to Clomid, behaves in the same manner in all tissues, and is a mixed estrogen agonist/antagonist of the same type as Clomid. The two molecules are also very similar in structure. It is not correct that Nolvadex reduces levels of estrogen: Rather, it blocks estrogen from estrogen receptors and, in those tissues where it is an antagonist, causes the receptor to do nothing.
The claim that Nolvadex reduces gains should not be taken too seriously. The fact is that any number of bodybuilders have made excellent gains while using Nolvadex.
Tamoxifen Citrate Benefits:
A. Tamoxife slows or stops the growth of cancer cells that are already present in the body. It helps keep the original breast cancer from coming back and helps prevent new cancer in the opposite breast. It also reduces the risk of breast cancer in women who have a high risk for this disease.
B. Tamoxife is used to prevent and treat breast cancers that test positive for estrogen receptors (ER+). It blocks the effects that the hormone estrogen has on cancer cells and lowers the chance that breast cancer will grow. It is often called an “anti-estrogen.”
C. Tamoxife is highly effective in lowering the risk of breast cancer recurrence. In women who have already had breast cancer, tamoxifen also lowers the risk of breast cancer in the opposite breast (contralateral)
D. For postmenopausal women, a two-stage treatment using tamoxife and then an aromatase inhibitor,
Tamoxifen Citrate COA
|Characteristics||White crystalline powder||conforms|
|Assay||99 ~ 101.0%||99.51%|
|Loss on drying||≤ 0.5%||0.24%|
|Identification||IR, UV conform||conforms|
|Residue on ignition||≤ 0.2%||0.06%|
|Heavy metals||≤ 0.001%||0.0006%|
|Related substances||Total: ≤ 1.0%||0.37%|
|Individual: ≤ 0.5%||0.17%|
|Organic volatile impurities||conform||conform|